Pfizer (PFE)

Other Income/Expenses (Net)

-$5.36B

Quarterly · Period ending: · USD

PFE logo

PFE Other Income/Expenses (Net)

Latest reported-$5.36B
PFE Quarterly Other Income/Expenses (Net) (-$1.01B → -$5.36B)
High-resolution chart · PNG

PFE other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-5,359,000,000
-862,000,000
-5,330,000,000
-216,000,000
-531,000,000
-1,840,000,000
-5,735,000,000
-253,000,000
-1,982,000,000
-1,138,000,000
-2,866,000,000
-346,000,000
-82,000,000
-415,000,000
-117,000,000
-698,000,000
-1,500,000,000
-993,000,000
547,000,000
93,000,000
961,000,000
881,000,000
-367,000,000
-1,930,000,000
515,000,000
-262,000,000
-3,552,000,000
7,358,000,000
-62,000,000
-176,000,000
-4,201,000,000
281,000,000
464,000,000
79,000,000
-1,531,000,000
-296,000,000
-58,000,000
-201,000,000
-1,770,000,000
-2,072,000,000
-1,383,000,000
-471,000,000
-2,615,000,000
-1,242,000,000
-142,000,000
-15,000,000
-474,000,000
-76,000,000
-28,000,000
-681,000,000
-617,000,000
-644,000,000
887,000,000
-504,000,000
-1,539,000,000
-1,449,000,000
-872,000,000
-2,371,000,000
-1,986,000,000
-1,637,000,000
-901,000,000
-1,721,000,000
-1,529,000,000
-826,000,000
-1,205,000,000
-1,190,000,000
-3,423,000,000
-391,000,000
-531,000,000
-554,000,000
-3,439,000,000
-1,100,000,000
-402,000,000
-243,000,000
394,000,000
-195,000,000
-564,000,000
-693,000,000
-883,000,000
94,000,000
-422,000,000
-43,000,000
-274,000,000
-1,719,000,000
-472,000,000
-1,259,000,000
-1,196,000,000
-473,000,000
-187,000,000
-1,982,000,000
-1,842,000,000
-98,000,000
-5,271,000,000
-270,000,000
-190,000,000
-165,000,000
-103,000,000
-117,000,000
-179,000,000
-85,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.